Cytokine Release Syndrome (crs) - Neonatal Disorders

Relevant Publications

Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA reporting system.

Issue Release: 2024

First-in-human clinical trial results with ABBV-184, a first-in-class T-cell Receptor/Anti-CD3 bispecific protein, in adults with Previously treated AML or NSCLC.

Issue Release: 2024

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis.

Issue Release: 2024

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

Issue Release: 2024

Matching-adjusted indirect comparisons of axicabtagene ciloleucel to mosunetuzumab for the treatment of relapsed/refractory follicular lymphoma.

Issue Release: 2024

Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors.

Issue Release: 2024

IL-6 Blockade in Cytokine Storm Syndromes.

Issue Release: 2024

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Issue Release: 2024

Optimization Strategies in CAR T-cell Therapy: A Comprehensive Evaluation of Cytopenia, HLH/MAS, and Other Adverse Events.

Issue Release: 2024

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

Issue Release: 2024

S309-CAR-NK cells bind the Omicron variants and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.

Issue Release: 2024

Acute kidney injury after CAR-T cell therapy: exploring clinical patterns, management, and outcomes.

Issue Release: 2024

An Early Neurological Indicator of Immune Effector Cell-Associated Neurotoxicity Syndrome.

Issue Release: 2024

Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb.

Issue Release: 2024

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma.

Issue Release: 2024

Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.

Issue Release: 2024

Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.

Issue Release: 2024

The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.

Issue Release: 2024

Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)-T-Cell therapy.

Issue Release: 2024

How can technology assist pediatricians in balancing their clinical and certification requirements?

What Conditions Do Pediatric Emergency Physicians Treat?

When Should You See a Pediatric Cardiologist?

Why are Social Behaviors Important?

How can parents set balanced expectations?

What are Spinal Deformities in Neonates?

What are the Recommendations for Post-Delivery Pediatric Visits?

What are Complex Carbohydrates?

What Conditions Can ERG Diagnose in Children?

What Are Neural Connections?

Cytokine Release Syndrome (crs) - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics